Livestock genome editing tools /

Livestock Genome Editing Tools introduces applications and improvements to a series of new genome editing techniques in livestock, such as pigs, cattle, and sheep.These tools include zinc finger nucleases (ZFN), transcription activator-like effector nucleases (TALEN), and the clustered regularly int...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Beste egile batzuk: Li, Kui
Formatua: eBook
Hizkuntza:ingelesa
Argitaratua: London : Academic Press, 2024.
Gaiak:
Sarrera elektronikoa:ScienceDirect
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Aurkibidea:
  • 2.3.8.1 Applications of CRISPR/Cas9 genome editing
  • 2.3.9 Applications of gene expression regulation
  • 2.3.10 Prospects
  • 2.4 Base editing
  • 2.4.1 DNA editing technologies
  • 2.4.1.1 Cytosine base editor technology
  • 2.4.1.2 Adenine-based editor technology
  • 2.4.1.3 RNA editing technology
  • 2.4.1.4 Applications of single-base editing technology
  • 2.4.2 Summary and prospects of single-base editing technology
  • References
  • 3 Associated technologies for genome editing
  • 3.1 Pronuclear microinjection
  • 3.1.1 Generation of genetically engineered pigs using pronuclear microinjection technology
  • 3.1.1.1 Collection and culture of pronuclear-stage embryos of pigs
  • 3.1.1.1.1 Collection of pronuclear-stage embryos of pigs fertilized under in vivo conditions
  • Preparation of donor sows
  • Superovulation and fertilization of donor sows
  • Recovery of pronuclear-stage embryos
  • Selection of pronuclear-stage embryos
  • 3.1.1.1.2 In vitro maturation of porcine oocytes and production of pronuclear-stage embryos fertilized under in vitro condi...
  • In vitro maturation of porcine oocytes
  • Treatment of mature porcine oocytes
  • Pretreatment of porcine sperm and in vitro fertilization
  • 3.1.1.1.3 In vitro maturation of porcine oocytes and production of pronuclear-stage embryos by intracytoplasmic sperm injection
  • Pretreatment of sperm
  • Preparation of the intracytoplasmic sperm injection operation dish
  • Intracytoplasmic sperm injection process
  • 3.1.1.2 Production and purification of the target gene fragments
  • 3.1.1.3 Microinjection of zygotes
  • 3.1.1.4 Preparation of recipient sows
  • 3.1.1.5 Embryo transfer
  • 3.1.1.6 Postoperative management of sows and identification of positive individuals
  • 3.1.2 Research status of genetically engineered animal generation by pronuclear microinjection
  • 3.2 Cytoplasmic injection.
  • 3.2.1 Research progress on cytoplasmic injection technology
  • 3.2.2 Mechanism for obtaining transgenes via cytoplasmic injection
  • 3.2.3 Factors affecting cytoplasmic injection
  • 3.2.3.1 Injection technique
  • 3.2.3.2 Size of the zygotes
  • 3.2.3.3 Structure and concentration of exogenous genes
  • 3.2.3.4 Assisted coinjection of other components
  • 3.2.3.5 Injection of a transposon system
  • 3.2.4 Comparison of cytoplasmic and pronuclear microinjections
  • 3.2.4.1 Survival rate of injected embryos
  • 3.2.4.2 Transgenesis efficiency
  • 3.2.4.3 Formation of chimeras
  • 3.2.4.4 Costs
  • 3.2.4.5 Application prospects for CI
  • 3.3 Somatic cell nuclear transfer technology
  • 3.3.1 Introduction of somatic cell nuclear transfer technology
  • 3.3.2 The main methods and processes of somatic cell cloning
  • 3.3.2.1 Preparation of nuclear donor cells
  • 3.3.2.2 Oocyte collection and in vitro maturation
  • 3.3.2.3 Enucleation of recipient oocytes
  • 3.3.2.4 Nuclear transfer of donor cells
  • 3.3.2.5 Fusion and activation of reconstructed embryos
  • 3.3.2.6 In vitro culture and transplantation of reconstructed embryos
  • 3.3.2.7 Care of sows during pregnancy and farrowing
  • 3.3.3 Operation for pig embryo transfer
  • 3.3.3.1 Selection of recipient sows
  • 3.3.3.2 Induction of anesthesia and securing the pig
  • 3.3.3.3 Maintenance of anesthesia and embryo transfer
  • 3.3.3.4 Suturing the incision
  • 3.3.3.5 Care of newborn piglets
  • 3.3.3.5.1 Prevention of the birth of disadvantaged piglets
  • 3.3.3.5.2 Attending and assisting during farrowing
  • 3.3.3.5.3 First aid for dying piglets after birth
  • 3.3.3.5.4 Colostrum intake of newborn piglets
  • 3.3.3.5.5 Crossfostering of newborn piglets
  • 3.3.3.5.6 Environmental requirements for newborn piglets
  • 3.3.3.5.7 Timely iron supplementation for newborn piglets
  • 3.3.3.5.8 Vaccination for piglets.
  • 3.3.4 Present problems in somatic cell cloning technology
  • 3.3.4.1 Low cloning efficiency and low survival rate of offspring
  • 3.3.4.2 The abnormal development of the placenta
  • 3.3.4.3 The source of mitochondria
  • 3.3.4.4 The abnormal process of reprogramming
  • 3.3.5 The prospects of somatic cell cloning technology
  • 3.4 Electroporation
  • 3.4.1 Model and mechanism of electroporation
  • 3.4.2 Application of electroporation in vivo
  • 3.4.3 Factors affecting the efficiency of electroporation
  • 3.4.4 The problems and prospects of electroporation technology
  • 3.5 RNA interference technology
  • 3.5.1 The discovery of RNAi
  • 3.5.2 The mechanism of RNAi
  • 3.5.2.1 Initiation stage
  • 3.5.2.2 Maintenance stage
  • 3.5.2.3 Signal amplification stage
  • 3.5.3 The biological characteristics of RNAi
  • 3.5.4 Factors affecting the efficiency of RNAi
  • 3.5.4.1 The construction of RNAi
  • 3.5.4.2 The modification of RNAi sequences
  • 3.5.4.3 Transfection efficiency
  • 3.5.5 Problems in the application of RNAi technology
  • 3.5.5.1 Immune response
  • 3.5.5.2 Off-target effect
  • 3.5.5.3 Saturation phenomenon
  • 3.5.6 The application of RNAi
  • 3.5.6.1 Gene function research
  • 3.5.6.2 Gene therapy for genetic disease
  • 3.5.6.3 The improvement of livestock breed
  • 3.6 Transgenic technology of viral vectors
  • 3.6.1 Lentiviral vectors
  • 3.6.1.1 The structure and source of lentiviral vectors
  • 3.6.1.2 The construction of lentiviral vectors
  • 3.6.1.3 Advantages and disadvantages of lentiviral vectors
  • 3.6.1.4 Applications of lentiviral vectors
  • 3.6.2 Adenoviral vectors
  • 3.6.2.1 The structure and classification of adenovirus
  • 3.6.2.2 The advantages and disadvantages of adenoviral vectors
  • 3.6.2.3 Applications of adenovirus vectors
  • 3.6.2.3.1 Applications in vaccine research
  • 3.6.2.3.2 Gene therapy
  • 3.6.3 Adeno-associated virus vector.